CNVVF (Convatec Group) Operating Margin %: 16.42% (As of Dec. 2025) — 40% Above Median


CNVVF Convatec Group PLC CNVVF
77 GF Score
Price $2.73
GF Value $3.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Convatec Group Operating Margin %?

Convatec Group CNVVF 77 Operating Margin % is 16.42% as of Dec. 2025, which is 40% above its 10-year median of 11.76. GuruFocus rates CNVVF with a GF Score™ of 77/100 and a GF Value™ of $3.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Convatec Group ranks better than 79.78% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Convatec Group's Operating Income for the six months ended in Dec. 2025 was $207 Mil. Convatec Group's Revenue for the six months ended in Dec. 2025 was $1,259 Mil. Therefore, Convatec Group's Operating Margin % for the quarter that ended in Dec. 2025 was 16.42%.

Good Sign:

Convatec Group PLC operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Convatec Group's Operating Margin % or its related term are showing as below:

CNVVF' s Operating Margin % Range Over the Past 10 Years
Min: 5.3   Med: 11.76   Max: 15.83
Current: 15.83


CNVVF's Operating Margin % is ranked better than
79.78% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 3.465 vs CNVVF: 15.83

Convatec Group's 5-Year Average Operating Margin % Growth Rate was 9.00% per year.

Convatec Group's Operating Income for the six months ended in Dec. 2025 was $207 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $386 Mil.


Convatec Group  (OTCPK:CNVVF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Convatec Group Operating Margin % Related Terms


Convatec Group Operating Margin % Historical Data

* Premium members only.

The historical data trend for Convatec Group's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Convatec Group Operating Margin % Chart

Convatec Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.99 10.67 12.38 14.50 15.83

Convatec Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.05 13.40 15.55 15.19 16.42

CNVVF vs ISRG, BDX, MDLN: Operating Margin % Comparison

For the Medical Instruments & Supplies subindustry, Convatec Group's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Convatec Group Operating Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Convatec Group's Operating Margin % falls into.


CNVVF
77GF Score
Convatec Group PLC CNVVF
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Convatec Group Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Convatec Group's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=386 / 2439
=15.83 %

Convatec Group's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=206.8 / 1259.1
=16.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 16.42% mean?
Convatec Group (CNVVF) has a Operating Margin % of 16.42% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Convatec Group and its competitors. This is 40% above median its historical median of 11.76. Over the past decade, Convatec Group's Operating Margin % has ranged from 5.30 to 15.83. According to the industry distribution chart, Convatec Group ranks #165 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 20.2%.
Is Convatec Group's Operating Margin % too high?
Convatec Group's current Operating Margin % of 16.42% is 40% above median its 10-year median of 11.76. Over the past 10 years, this metric has ranged from a low of 5.30 to a high of 15.83. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Convatec Group's value of 16.42% is 373.9% above this industry median. Based on the distribution chart, Convatec Group ranks #165 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Convatec Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #165 out of 816 companies for Operating Margin %. This places Convatec Group in the top 20% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. Convatec Group's value of 16.42% is 373.9% above this benchmark. Historically, Convatec Group's own Operating Margin % has ranged from 5.30 to 15.83 over the past decade. While the company's 10-year median is 11.76 vs. the industry median of 3.47, Convatec Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Convatec Group's current Operating Margin % of 16.42% is 373.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Convatec Group and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Convatec Group's current Operating Margin % is 16.42%, which is 40% above median its own 10-year median of 11.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (CNVVF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.08, compared to a current price of $2.73 — trading 11.4% below its estimated fair value. The current Operating Margin % is 16.42%, which is 40% above median its 10-year median of 11.76 and 373.9% above the Medical Devices & Instruments industry median of 3.47. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Convatec Group (CNVVF), the current Operating Margin % is 16.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (CNVVF) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of $2.73 is trading 11.4% below its estimated GF Value™ of $3.08. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for CNVVF:

  • Operating Margin %: 16.42% (40% above median its 10-year median of 11.76)
  • GF Value™: $3.08 vs. price of $2.73 (11.4% below fair value)
  • GF Score™: 77/100 with 4 warning signs
  • Industry Position: 373.9% above the Medical Devices & Instruments median (#165 of 816)

No single metric tells the full story. See the CNVVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score

Get the complete analysis for CNVVF

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.73
Price
$3.08
GF Value